These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Deciphering the Relationship between SARS-CoV-2 and Cancer. Costanzo M; De Giglio MAR; Roviello GN Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175509 [TBL] [Abstract][Full Text] [Related]
4. Regulation of Autophagy in Cells Infected With Oncogenic Human Viruses and Its Impact on Cancer Development. Vescovo T; Pagni B; Piacentini M; Fimia GM; Antonioli M Front Cell Dev Biol; 2020; 8():47. PubMed ID: 32181249 [TBL] [Abstract][Full Text] [Related]
5. The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis. Bayik D; Lee J; Lathia JD Exp Suppl; 2022; 113():189-217. PubMed ID: 35165865 [TBL] [Abstract][Full Text] [Related]
6. Human Oncogenic Viruses: Characteristics and Prevention Strategies-Lessons Learned from Human Papillomaviruses. Galati L; Chiantore MV; Marinaro M; Di Bonito P Viruses; 2024 Mar; 16(3):. PubMed ID: 38543781 [TBL] [Abstract][Full Text] [Related]
7. Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention. Saha A; Kaul R; Murakami M; Robertson ES Cancer Biol Ther; 2010 Nov; 10(10):961-78. PubMed ID: 21084867 [TBL] [Abstract][Full Text] [Related]
8. The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment. Dzobo K OMICS; 2021 Jun; 25(6):358-371. PubMed ID: 34037476 [TBL] [Abstract][Full Text] [Related]
9. Tumorigenesis and diagnostic practice applied in two oncogenic viruses: Epstein Barr virus and T-cell lymphotropic virus-1-Mini review. Manivannan AC; Devaraju V; Velmurugan P; Sathiamoorthi T; Sivakumar S; Subbiah SK; Ravi AV Biomed Pharmacother; 2021 Oct; 142():111974. PubMed ID: 34343895 [TBL] [Abstract][Full Text] [Related]
10. Visualization and quantification of Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525 [TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory effects of myeloid-derived suppressor cells in diseases: Role in cancer and infections. Tamadaho RSE; Hoerauf A; Layland LE Immunobiology; 2018; 223(4-5):432-442. PubMed ID: 29246400 [TBL] [Abstract][Full Text] [Related]
12. Molecular and cellular interplay in virus-induced tumors in solid organ recipients. Gallo A; Miele M; Badami E; Conaldi PG Cell Immunol; 2019 Sep; 343():103770. PubMed ID: 29523417 [TBL] [Abstract][Full Text] [Related]
13. Myeloid-Derived Suppressor Cells: The Expanding World of Helminth Modulation of the Immune System. Stevenson MM; Valanparambil RM; Tam M Front Immunol; 2022; 13():874308. PubMed ID: 35757733 [TBL] [Abstract][Full Text] [Related]
14. Oncogenes and RNA splicing of human tumor viruses. Ajiro M; Zheng ZM Emerg Microbes Infect; 2014 Sep; 3(9):e63. PubMed ID: 26038756 [TBL] [Abstract][Full Text] [Related]
15. Human viral oncogenesis: a cancer hallmarks analysis. Mesri EA; Feitelson MA; Munger K Cell Host Microbe; 2014 Mar; 15(3):266-82. PubMed ID: 24629334 [TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer. Tcyganov EN; Hanabuchi S; Hashimoto A; Campbell D; Kar G; Slidel TW; Cayatte C; Landry A; Pilataxi F; Hayes S; Dougherty B; Hicks KC; Mulgrew K; Tang CA; Hu CA; Guo W; Grivennikov S; Ali MA; Beltra JC; Wherry EJ; Nefedova Y; Gabrilovich DI J Clin Invest; 2021 Aug; 131(16):. PubMed ID: 34228641 [TBL] [Abstract][Full Text] [Related]
17. Myeloid-derived suppressor cells: the dark knight or the joker in viral infections? Goh C; Narayanan S; Hahn YS Immunol Rev; 2013 Sep; 255(1):210-21. PubMed ID: 23947357 [TBL] [Abstract][Full Text] [Related]
18. The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers. Fan R; De Beule N; Maes A; De Bruyne E; Menu E; Vanderkerken K; Maes K; Breckpot K; De Veirman K Front Immunol; 2022; 13():1016059. PubMed ID: 36304465 [TBL] [Abstract][Full Text] [Related]
19. CD205 Fu C; Fu Z; Jiang C; Xia C; Zhang Y; Gu X; Zheng K; Zhou D; Tang S; Lyu S; Ma S Cancer Sci; 2021 Mar; 112(3):1011-1025. PubMed ID: 33368883 [TBL] [Abstract][Full Text] [Related]
20. STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion. Zhang CX; Ye SB; Ni JJ; Cai TT; Liu YN; Huang DJ; Mai HQ; Chen QY; He J; Zhang XS; Zeng YX; Li J; Cui J Cell Death Differ; 2019 Nov; 26(11):2314-2328. PubMed ID: 30816302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]